Rema Moore

536 total citations
16 papers, 412 citations indexed

About

Rema Moore is a scholar working on Pharmacology, Physiology and Biochemistry. According to data from OpenAlex, Rema Moore has authored 16 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 5 papers in Physiology and 3 papers in Biochemistry. Recurrent topics in Rema Moore's work include Pharmacology and Obesity Treatment (9 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Pain Mechanisms and Treatments (2 papers). Rema Moore is often cited by papers focused on Pharmacology and Obesity Treatment (9 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Pain Mechanisms and Treatments (2 papers). Rema Moore collaborates with scholars based in United States, United Kingdom and Switzerland. Rema Moore's co-authors include Jianguo Zhi, L Finch, David B. Campbell, Robin E. Buckingham, Mark Boldrin, Roberto Guerciolini, Tamara Bucher, Peter E. Hicks, M. Fitchet and Hermann Toplak and has published in prestigious journals such as British Journal of Pharmacology, International Journal of Obesity and The Journal of Clinical Psychiatry.

In The Last Decade

Rema Moore

16 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rema Moore United States 11 206 112 102 87 64 16 412
Ida Rudberg Norway 9 173 0.8× 73 0.7× 38 0.4× 135 1.6× 69 1.1× 11 631
Mark Leibowitz United States 11 185 0.9× 112 1.0× 54 0.5× 75 0.9× 77 1.2× 16 522
Daniela Carmen Ababei Romania 14 245 1.2× 168 1.5× 83 0.8× 132 1.5× 85 1.3× 32 647
Ya Miao China 15 66 0.3× 144 1.3× 73 0.7× 128 1.5× 55 0.9× 33 556
Chaichan Sangdee Thailand 14 142 0.7× 80 0.7× 26 0.3× 99 1.1× 83 1.3× 28 480
Yueshan Hu United States 13 257 1.2× 90 0.8× 91 0.9× 243 2.8× 30 0.5× 18 750
Gayle L. Crozier Switzerland 11 165 0.8× 151 1.3× 110 1.1× 95 1.1× 23 0.4× 17 572
Caroline Curry Martins Brazil 14 79 0.4× 108 1.0× 120 1.2× 134 1.5× 20 0.3× 23 598
K. Sugawara Japan 14 152 0.7× 48 0.4× 35 0.3× 92 1.1× 77 1.2× 29 537
Jonathan A. Farrimond United Kingdom 10 147 0.7× 46 0.4× 73 0.7× 111 1.3× 59 0.9× 12 366

Countries citing papers authored by Rema Moore

Since Specialization
Citations

This map shows the geographic impact of Rema Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rema Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rema Moore more than expected).

Fields of papers citing papers by Rema Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rema Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rema Moore. The network helps show where Rema Moore may publish in the future.

Co-authorship network of co-authors of Rema Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Rema Moore. A scholar is included among the top collaborators of Rema Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rema Moore. Rema Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Umbricht, Daniel, Markus Niggli, Patricia Sanwald Ducray, et al.. (2020). Randomized, Double-Blind, Placebo-Controlled Trial of the mGlu2/3 Negative Allosteric Modulator Decoglurant in Partially Refractory Major Depressive Disorder. The Journal of Clinical Psychiatry. 81(4). 31 indexed citations
2.
Umbricht, Daniel, Markus Niggli, Patricia Sanwald Ducray, et al.. (2015). P.2.f.021 Results of a double-blind placebo-controlled study of the antidepressant effects of the mGLU2 negative allosteric modulator RG1578. European Neuropsychopharmacology. 25. S447–S447. 8 indexed citations
3.
Bellows, Laura & Rema Moore. (2013). Diet and hypertension. Digital Collections of Colorado (Colorado State University). 1 indexed citations
4.
5.
Toplak, Hermann, A. Hamann, Rema Moore, et al.. (2006). Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study. International Journal of Obesity. 31(1). 138–146. 60 indexed citations
6.
Zhi, Jianguo, et al.. (2003). The Effect of Short-Term (21-Day) Orlistat Treatment on the Physiologic Balance of Six Selected Macrominerals and Microminerals in Obese Adolescents. Journal of the American College of Nutrition. 22(5). 357–362. 34 indexed citations
7.
Zhi, Jianguo, et al.. (2003). Effects of Orlistat, a Lipase Inhibitor, on the Pharmacokinetics of Three Highly Lipophilic Drugs (Amiodarone, Fluoxetine, and Simvastatin) in Healthy Volunteers. The Journal of Clinical Pharmacology. 43(4). 428–435. 45 indexed citations
8.
Zhi, Jianguo, et al.. (2002). Pharmacokinetic Evaluation of the Possible Interaction between Selected Concomitant Medications and Orlistat at Steady State in Healthy Subjects. The Journal of Clinical Pharmacology. 42(9). 1011–1019. 10 indexed citations
9.
Zhi, Jianguo, et al.. (2002). Pharmacokinetic Evaluation of the Possible Interaction between Selected Concomitant Medications and Orlistat at Steady State in Healthy Subjects. The Journal of Clinical Pharmacology. 42(9). 1011–1019. 19 indexed citations
10.
Zhi, Jianguo, et al.. (2002). Pharmacokinetic Evaluation of the Possible Interaction between Selected Concomitant Medications and Orlistat at Steady State in Healthy Subjects. The Journal of Clinical Pharmacology. 42(9). 1011–1019. 41 indexed citations
11.
Guerciolini, Roberto, et al.. (2001). Comparative Evaluation of Fecal Fat Excretion Induced by Orlistat and Chitosan. Obesity Research. 9(6). 364–367. 52 indexed citations
12.
Moore, Rema, Sally Collins, & HJ McQuay. (1997). Variation in the placebo effect: The impact on individual trials and consequences for meta-analysis. 8. 469–476. 2 indexed citations
13.
Campbell, David B. & Rema Moore. (1981). The pharmacology and clinical pharmacology of indapamide.. PubMed. 57 Suppl 2. 7–17. 33 indexed citations
14.
Finch, L, Peter E. Hicks, & Rema Moore. (1977). Changes in vascular reactivity in experimental hypertensive animals following treatment with indapamide. Journal of Pharmacy and Pharmacology. 29(1). 739–743. 28 indexed citations
15.
Buckingham, Robin E., Thomas C. Hamilton, & Rema Moore. (1976). PROLONGED EFFECTS OF p‐CHLOROPHENYLALANINE ON THE BLOOD PRESSURE OF CONSCIOUS NORMOTENSIVE AND DOCA/SALINE HYPERTENSIVE RATS. British Journal of Pharmacology. 56(1). 69–75. 9 indexed citations
16.
Finch, L, Robin E. Buckingham, Rema Moore, & Tamara Bucher. (1975). Evidence for a central α-sympathomimetic action of Clonidine in the rat. Journal of Pharmacy and Pharmacology. 27(3). 181–186. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ida Rudberg Breakdown of academic impact, for papers by Mark Leibowitz Breakdown of academic impact, for papers by Daniela Carmen Ababei Breakdown of academic impact, for papers by Ya Miao Breakdown of academic impact, for papers by Chaichan Sangdee Breakdown of academic impact, for papers by Yueshan Hu Breakdown of academic impact, for papers by Gayle L. Crozier Breakdown of academic impact, for papers by Caroline Curry Martins Breakdown of academic impact, for papers by K. Sugawara Breakdown of academic impact, for papers by Jonathan A. Farrimond
Rankless by CCL
2026